172 related articles for article (PubMed ID: 37035750)
1. Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers.
Wang Y; Bi X; Luo Z; Wang H; Ismtula D; Guo C
Front Genet; 2023; 14():1093163. PubMed ID: 37035750
[No Abstract] [Full Text] [Related]
2. Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.
Chen ZY; Wang PW; Shieh DB; Chiu KY; Liou YM
J Biomed Sci; 2015 Oct; 22():90. PubMed ID: 26482896
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
4. Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma.
Alsofyani AA; Nedjadi T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958747
[TBL] [Abstract][Full Text] [Related]
5. Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer.
Wu Y; Zheng J; Yan Y; Liu J; Zhou Y
Int J Gen Med; 2022; 15():927-936. PubMed ID: 35115818
[TBL] [Abstract][Full Text] [Related]
6. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
[TBL] [Abstract][Full Text] [Related]
8. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
Jin D; Yuan L; Li F; Wang S; Mao Y
BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
[TBL] [Abstract][Full Text] [Related]
9. Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.
Chen Z; Li K; Yin X; Li H; Li Y; Zhang Q; Wang H; Qiu Y
J Cancer; 2019; 10(5):1288-1296. PubMed ID: 30854138
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
11. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
[No Abstract] [Full Text] [Related]
12. Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
Roy S; Esmaeilniakooshkghazi A; Patnaik S; Wang Y; George SP; Ahrorov A; Hou JK; Herron AJ; Sesaki H; Khurana S
Gastroenterology; 2018 Apr; 154(5):1405-1420.e2. PubMed ID: 29274870
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
14. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
15. Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis.
Zhang Y; Luo X; Lin J; Fu S; Feng P; Su H; He X; Liang X; Liu K; Deng W
J Oncol; 2020; 2020():1980368. PubMed ID: 32377190
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
17. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
Ning Y; Li Y; Wang H
Front Genet; 2023; 14():1108167. PubMed ID: 36713082
[No Abstract] [Full Text] [Related]
18. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
19. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
Ding JT; Yu XT; He JH; Chen DZ; Guo F
Front Genet; 2022; 13():912003. PubMed ID: 35783266
[No Abstract] [Full Text] [Related]
20. Predictive value of serum gelsolin and Gc globulin in sepsis - a pilot study.
Horváth-Szalai Z; Kustán P; Szirmay B; Lakatos Á; Christensen PH; Huber T; Bugyi B; Mühl D; Ludány A; Miseta A; Kovács GL; Kőszegi T
Clin Chem Lab Med; 2018 Jul; 56(8):1373-1382. PubMed ID: 29320362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
